Quinn Opportunity Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.85M | Sell |
81,499
-29,500
| -27% | -$2.27M | 0.31% | 79 |
|
|
2025
Q4 | $8.81M | Hold |
110,999
| – | – | 0.37% | 66 |
|
|
2025
Q3 | $8.37M | Sell |
110,999
-40,300
| -27% | -$2.76M | 0.59% | 44 |
|
|
2025
Q2 | $10.4M | Sell |
151,299
-329,551
| -69% | -$21.6M | 0.87% | 25 |
|
|
2025
Q1 | $32.6M | Sell |
480,850
-4,000
| -0.8% | -$239K | 2.23% | 4 |
|
|
2024
Q4 | $21.8M | Buy |
484,850
+90,400
| +23% | +$5.07M | 1.47% | 12 |
|
|
2024
Q3 | $24.8M | Buy |
394,450
+98,719
| +33% | +$5.76M | 2.4% | 7 |
|
|
2024
Q2 | $17.5M | Buy |
295,731
+131,400
| +80% | +$8.22M | 1.99% | 7 |
|
|
2024
Q1 | $13.1M | Buy |
164,331
+4,000
| +2% | +$306K | 1.45% | 18 |
|
|
2023
Q4 | $12.7M | Buy |
160,331
+4,000
| +3% | +$285K | 1.32% | 17 |
|
|
2023
Q3 | $10.9M | Buy |
156,331
+19,506
| +14% | +$1.38M | 1.41% | 14 |
|
|
2023
Q2 | $9.46M | Sell |
136,825
-16,440
| -11% | -$1.17M | 1.28% | 20 |
|
|
2023
Q1 | $11.4M | Buy |
153,265
+101,000
| +193% | +$8.47M | 1.14% | 28 |
|
|
2022
Q4 | $4.87M | Buy |
52,265
+48,385
| +1,247% | +$4.67M | 0.6% | 39 |
|
|
2022
Q3 | $370K | Buy |
+3,880
| New | +$384K | 0.04% | 142 |
|
|
2022
Q2 | – | Sell |
-29,000
| Closed | -$2.94M | – | 200 |
|
|
2022
Q1 | $2.94M | Sell |
29,000
-72,000
| -71% | -$7.56M | 0.13% | 78 |
|
|
2021
Q4 | $10.4M | Sell |
101,000
-35,000
| -26% | -$3.23M | 0.63% | 33 |
|
|
2021
Q3 | $11.5M | Hold |
136,000
| – | – | 0.74% | 31 |
|
|
2021
Q2 | $11.3M | Buy |
136,000
+26,000
| +24% | +$2.13M | 0.71% | 34 |
|
|
2021
Q1 | $8.28M | Buy |
110,000
+10,000
| +10% | +$728K | 0.52% | 43 |
|
|
2020
Q4 | $6.83M | Buy |
100,000
+8,000
| +9% | +$520K | 0.58% | 41 |
|
|
2020
Q3 | $5.37M | Buy |
92,000
+20,500
| +29% | +$1.28M | 0.57% | 35 |
|
|
2020
Q2 | $4.64M | Hold |
71,500
| – | – | 0.58% | 33 |
|
|
2020
Q1 | $4.24M | Sell |
71,500
-5,500
| -7% | -$367K | 0.64% | 32 |
|
|
2019
Q4 | $5.72M | Sell |
77,000
-40,758
| -35% | -$2.86M | 0.7% | 31 |
|
|
2019
Q3 | $7.43M | Sell |
117,758
-124,592
| -51% | -$7.38M | 0.9% | 28 |
|
|
2019
Q2 | $13.2M | Buy |
242,350
+9,000
| +4% | +$485K | 1.64% | 12 |
|
|
2019
Q1 | $12.6M | Buy |
233,350
+165,500
| +244% | +$10.2M | 1.72% | 12 |
|
|
2018
Q4 | $4.45M | Buy |
67,850
+8,000
| +13% | +$597K | 0.62% | 28 |
|
|
2018
Q3 | $4.71M | Buy |
59,850
+20,000
| +50% | +$1.43M | 0.67% | 32 |
|
|
2018
Q2 | $2.56M | Buy |
39,850
+27,000
| +210% | +$1.78M | 0.34% | 57 |
|
|
2018
Q1 | $799K | Hold |
12,850
| – | – | 0.1% | 102 |
|
|
2017
Q4 | $932K | Buy |
+12,850
| New | +$934K | 0.15% | 98 |
|
Other funds holding CVS
VCM
VPM
Quinn Opportunity Partners's CVS Position: Q1 2026 in Review
Quinn Opportunity Partners reduced its CVS Health (CVS) stake by 27% in Q1 2026, selling an estimated $2.27M and leaving 81,499 shares worth $5.85M. The position accounts for 0.31% of the portfolio, ranked #79.
Quinn Opportunity Partners first reported a position in CVS in Q4 2017 and has held it in 33 quarters since. The position peaked at $32.6M in Q1 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Quinn Opportunity Partners held 81,499 shares of CVS Health worth $5.85M as of Q1 2026.
- Quinn Opportunity Partners sold 29,500 CVS Health shares in Q1 2026, an estimated $2.27M.
- CVS Health made up 0.31% of Quinn Opportunity Partners's portfolio in Q1 2026, its #79 holding.
- Quinn Opportunity Partners first reported a position in CVS Health in Q4 2017 and has held it in 33 quarters since.
- Quinn Opportunity Partners's CVS Health position peaked at $32.6M in Q1 2025.
- 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Quinn Opportunity Partners's 13F filing for Q1 2026, filed 15 May 2026.